{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:47:45Z","timestamp":1790707665436,"version":"4.1.0"},"reference-count":48,"publisher":"Informa UK Limited","issue":"11","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1080\/14712598.2020.1806231","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T23:18:03Z","timestamp":1596583083000},"page":"1253-1259","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Daratumumab subcutaneous formulation for the treatment of multiple myeloma"],"prefix":"10.1080","volume":"20","author":[{"given":"Barry","family":"Paul","sequence":"first","affiliation":[{"name":"Division of Plasma Cell Disorders, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute\/Atrium Health, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam","family":"Hamadeh","sequence":"additional","affiliation":[{"name":"Division of Plasma Cell Disorders, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute\/Atrium Health, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shebli","family":"Atrash","sequence":"additional","affiliation":[{"name":"Division of Plasma Cell Disorders, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute\/Atrium Health, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Bhutani","sequence":"additional","affiliation":[{"name":"Division of Plasma Cell Disorders, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute\/Atrium Health, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Voorhees","sequence":"additional","affiliation":[{"name":"Division of Plasma Cell Disorders, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute\/Atrium Health, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Z.","family":"Usmani","sequence":"additional","affiliation":[{"name":"Division of Plasma Cell Disorders, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute\/Atrium Health, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,8,16]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-552059"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.380"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0155-7"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000524"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1309\/74R4TB90BUWH27JX"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90148-1"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21092"},{"key":"cit0009","author":"Jansen JM","year":"2012","journal-title":"Am Soc Hematol"},{"key":"cit0010","doi-asserted-by":"crossref","unstructured":"Overdijk MB, et al. Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. In MAbs. 2015. Taylor & Francis.","DOI":"10.1080\/19420862.2015.1007813"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.123"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003032"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-12-687749"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1813"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030759"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01120-4"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-705210"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506348"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817249"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714678"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31240-1"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606038"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607751"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-785246"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00143"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1829.1829"},{"key":"cit0027","volume-title":"DARAZALEX daratumumab product information","author":"Janssen","year":"2019"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00377"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31706"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0120-2"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-128515"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.08.001"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2229-9"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2018.1551442"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2006.05.027"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-012-0065-3"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000667"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.243790"},{"issue":"15","key":"cit0039","volume":"37","author":"Mateos M-V","year":"2019","journal-title":"Am Soc Clin Oncol"},{"issue":"5","key":"cit0040","first-page":"e370-e380","volume":"7","author":"*Mateos MV","year":"2020","journal-title":"Lancet Haematol"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.09.023"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005288"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32956-3"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30734-0"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000722"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113161"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1301"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0368"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2020.1806231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T01:49:38Z","timestamp":1620438578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2020.1806231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,16]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,1]]}},"alternative-id":["10.1080\/14712598.2020.1806231"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2020.1806231","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}